GFC Life Science Co., Ltd (KOSDAQ:388610)
South Korea flag South Korea · Delayed Price · Currency is KRW
11,410
-340 (-2.89%)
At close: Feb 23, 2026

GFC Life Science Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2021FY 2020FY 2019FY 2018FY 2017
Period Ending
Feb '26 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17
Debt / Equity Ratio
0.900.901.510.850.640.34
Debt / EBITDA Ratio
3.253.2513.64233.28--
Debt / FCF Ratio
20.7920.79----
Net Debt / Equity Ratio
0.760.761.410.700.530.09
Net Debt / EBITDA Ratio
2.722.7212.80191.73-5.07-0.93
Net Debt / FCF Ratio
17.4117.41-5.00-1.73-0.80-0.46
Asset Turnover
0.710.710.650.600.490.46
Inventory Turnover
11.1811.1812.8411.698.759.38
Quick Ratio
0.420.420.241.461.261.43
Current Ratio
0.530.530.341.721.831.66
Return on Equity (ROE)
21.78%21.78%-28.76%4.26%-4.65%-8.67%
Return on Assets (ROA)
4.42%4.42%-0.02%-2.37%-5.76%-4.89%
Return on Invested Capital (ROIC)
8.82%8.82%-0.04%-4.28%-11.51%-11.63%
Return on Capital Employed (ROCE)
12.50%12.50%-0.10%-4.30%-9.20%-9.80%
Buyback Yield / Dilution
0.04%-0.01%-0.02%-100.00%50.03%-0.06%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.